NASDAQ
LENZ Therapeutics, Inc. (LENZ) has a free cash flow growth of -1.62% as of Friday, May 29, 2026. This represents a 97.77% increase compared to its 12-month average of -72.73%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.